Whole-genome sequencing analysis in families with recurrent pregnancy loss: A pilot study
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0281934 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Tsegaselassie Workalemahu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Utah Health, Salt Lake City, Utah, United States of America. Hauptthemen laut MEDLINE: Abortion, Habitual. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NCATS NIH HHS, NIH HHS.
Abstract (Originalsprache)
One to two percent of couples suffer recurrent pregnancy loss and over 50% of the cases are unexplained. Whole genome sequencing (WGS) analysis has the potential to identify previously unrecognized causes of pregnancy loss, but few studies have been performed, and none have included DNA from families including parents, losses, and live births. We conducted a pilot WGS study in three families with unexplained recurrent pregnancy loss, including parents, healthy live births, and losses, which included an embryonic loss (0.9), impacting known genes (e.g., DICER1 , FBN2 , FLT4 , HERC1 , and TAOK1 ) involved in embryonic/fetal development and congenital abnormalities. Further, we identified inherited missense compound heterozygous SNVs impacting genes (e.g., VWA5B2 ) in two fetal death samples. The variants were not identified as compound heterozygous SNVs in live births and population controls, providing evidence for haplosufficient genes relevant to pregnancy loss. In this pilot study, we provide evidence for de novo and inherited SNVs relevant to pregnancy loss. Our findings provide justification for conducting WGS using larger numbers of families and warrant validation by targeted sequencing to ascertain causal variants. Elucidating genes causing pregnancy loss may facilitate the development of risk stratification strategies and novel therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, University of Utah Health, Salt Lake City, Utah, United States of America.
- Department of Human Genetics, University of Utah, Salt Lake City, Utah, United States of America.
- Intermountain Healthcare, Maternal-Fetal Medicine, Salt Lake City, Utah, United States of America.
- Department of Biomedical Informatics, University of Utah, Salt Lake City, Utah, United States of America.
- Department of Psychiatry, University of Utah, Salt Lake City, Utah, United States of America.
- DNA Sequencing Core, University of Utah, Salt Lake City, Utah, United States of America.
ORCID-Profile: Tsegaselassie Workalemahu
Förderung
- NIGMS NIH HHS
- NCATS NIH HHS
- NIH HHS
- National Center for Advancing Translational Sciences
- National Institute of General Medical Sciences
Zitieren
APA
Workalemahu, T., Avery, C., Lopez, S., Blue, N. R., Wallace, A., Quinlan, A. R., Coon, H., Warner, D., Varner, M. W., Branch, D. W., Jorde, L. B., & Silver, R. M. (2023). Whole-genome sequencing analysis in families with recurrent pregnancy loss: A pilot study. PLOS ONE. https://doi.org/10.1371/journal.pone.0281934
Vancouver
Workalemahu T, Avery C, Lopez S, Blue NR, Wallace A, Quinlan AR, et al. Whole-genome sequencing analysis in families with recurrent pregnancy loss: A pilot study. PLOS ONE. 2023. doi:10.1371/journal.pone.0281934
BibTeX
@article{Workalemahu2023,
author = {Workalemahu, Tsegaselassie and Avery, Cecile and Lopez, Sarah and Blue, Nathan R and Wallace, Amelia and Quinlan, Aaron R and Coon, Hilary and Warner, Derek and Varner, Michael W and Branch, D Ware and Jorde, Lynn B and Silver, Robert M},
title = {Whole-genome sequencing analysis in families with recurrent pregnancy loss: A pilot study},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0281934}
}
EUVIMED